Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production

Journal of Immunology

Volumn 166, Issue 4, 2001, Pages 2173-2177

  Rutschman, R ^a   Lang, R ^a   Hesse, M ^a   Ihle, J N ^a   Wynn, T A ^a   Murray, P J ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; ARGININE; BACTERIUM LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; ISOENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; STAT6 PROTEIN;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CATABOLITE REPRESSION; CELL DENSITY; CONTROLLED STUDY; ENZYME INHIBITION; INCUBATION TIME; LEUKOCYTE CULTURE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII;

EID: 0035865047     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.4.2173     Document Type: Article

References (35)

1. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
2. Nitric oxide and cell death
3. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene
4. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
5. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase
6. Role of interferon regulatory factor I in induction of nitric oxide synthase
7. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox
8. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β
9. Increased anti-mycobacterial immunity in interleukin-10-deficient mice
10. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor β1 null mouse
11. Mechanism of suppression of macrophage nitric oxide release by IL-13: Influence of the macrophage population
12. Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages
13. Modulation of murine macrophage function by IL-13
14. Interleukin-13 alters the activation state of murine macrophages in vitro: Comparison with interleukin-4 and interferon-γ
15. The IL-4 receptor: Signaling mechanisms and biologic functions
16. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
17. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
18. Determination of arginase activity in macrophages: A micromethod
19. Purification and properties of nitric oxide synthases
20. Epitope tagging of the human endoplasmic reticulum HSP70 protein, BiP, to facilitate analysis of BiP-substrate interactions
21. STAT6: Its role in interleukin 4-mediated biological functions
22. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
23. Essential role of Stat6 in IL-4 signalling
24. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice
25. IFN-γ and IL-4 differentially regulate inducible NO synthase gene expression through IRF-1 modulation
26. + T cells correlates with Th1/Th2 phenotype
27. Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells
28. Arginine metabolism: Nitric oxide and beyond
29. Arginase modulates nitric oxide production in activated macrophages
30. Regulation of arginase isoforms I and II by IL-4 in cultured murine peritoneal macrophages
31. STATs: Signal transducers and activators of transcription
32. Components of a Stat recognition code: Evidence for two layers of molecular selectivity
33. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α
34. Microenvironmental arginine depletion by macrophages in vivo
35. L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomaisis